The Centers for Disease Control and Prevention has released evidence-based recommendations to prevent and control Staphylococcus aureus in neonatal intensive care units, including strains resistant (MRSA) or sensitive (MSSA) to the antibiotic methicillin.

The recommendations supplement existing CDC recommendations for all health care settings based on a systematic review of the best available literature, the agency said.

“While MRSA has long been the focus of prevention efforts due to the difficulty in treating and eradicating it, recent studies have demonstrated that methicillin-sensitive S. aureus (MSSA) has morbidity and mortality equal to MRSA and occurs more frequently in NICU patients,” the guidelines note.

Related News Articles

Headline
Over 10,000 eligible nursing homes, or 76% of the field, will receive a portion of $333 million in COVID-19 Provider Relief Funds for meeting infection control…
Headline
Essa Mohamed, a National Institutes of Health Fellow at Mayo Clinic’s Department of Cardiovascular Medicine, speaks with Elisa Arespacochaga, vice president of…
Headline
Efforts by Spectrum Health, in Grand Rapids, Mich., to address health disparities in the African American and Latinx communities are yielding strong results.…
Headline
AHA’s Institute for Diversity and Health Equity talks with Deepa Sheth, M.D., oncologist and assistant professor of radiology at University of Chicago Medicine…
Headline
On this Institute for Diversity and Health Equity webinar, 2020 AHA Carolyn Boone Lewis Equity of Care Award honorees share efforts to deliver inclusive,…
Headline
A new analysis by Global Health 50/50, an initiative to advance gender equality in global health, sheds light on sex disparities in COVID-19 deaths.…